Nifty Labs Scales Up its API Powerhouse in Andhra Pradesh

Nifty Labs Private Limited is set to expand its Active Pharmaceuticals Ingredients (API) Manufacturing Unit located in IDA Kondapalli, Ibrahimpatnam Mandal, Krishna District, Andhra Pradesh, with a significant investment of 4 crores. This expansion project aims to increase the production capacity by 135.5 TPM (Tons Per Month) of Active Pharmaceuticals Ingredients, potentially involving enhancements to existing facilities, focusing on specific high-demand APIs, and creating employment opportunities within the region.

The expansion holds promising implications, potentially contributing to India's self-reliance in API production and reducing dependency on imports. It is expected to improve access to essential medicines, fostering affordability and availability. Additionally, this initiative could bolster India's position as a key player in the global pharmaceutical industry while fostering technological advancements that enhance operational efficiency and sustainability.

However, detailed information regarding project timelines, targeted APIs, environmental considerations, and the project's potential impact on employment is currently unavailable. Individuals seeking specific details or project progress are encouraged to directly contact Nifty Labs Private Limited or monitor their official communication channels for updates and comprehensive insights.

As on January,2024 Currently, the project is at the approvals stage. Awaiting authorization from the government. Other particulars have not yet been settled upon.

News by Rahul Yelligetti